A new pharmacological target for somatotroph pituitary adenomas

Bookmark and Share
Published: 1 Nov 2010
Views: 6679
Dr Sylvie Thirion - Université de la Méditerranée, Marseille, France
Dr Sylvie Thirion talks about her research that has identified GHS-R (ghrelin G-protein coupled receptor) as a possible new pharmacological target for the treatment of somatotroph pituitary adenomas. Dr Thirion discusses the interim results and her belief that this target will ultimately be exploited for the treatment of not just somatotroph adenomas but many other cancers as well.